Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 3
2005 5
2006 2
2007 2
2008 2
2009 1
2010 1
2011 3
2012 3
2013 1
2014 5
2015 3
2016 5
2017 15
2018 5
2019 7
2020 10
2021 10
2022 8
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Fujita A, Kataoka K, Takeuchi J, Nakano Y, Horiguchi E, Kaneko H, Ito Y, Terasaki H. Fujita A, et al. Among authors: kataoka k. Retina. 2021 Sep 1;41(9):e54. doi: 10.1097/IAE.0000000000003173. Retina. 2021. PMID: 33814538 No abstract available.
Reply.
Ra E, Ito Y, Kawano K, Iwase T, Kaneko H, Ueno S, Yasuda S, Kataoka K, Terasaki H. Ra E, et al. Among authors: kataoka k. Am J Ophthalmol. 2017 Aug;180:178-179. doi: 10.1016/j.ajo.2017.05.012. Epub 2017 May 31. Am J Ophthalmol. 2017. PMID: 28577756 No abstract available.
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: kataoka k. Sci Rep. 2023 May 30;13(1):8747. doi: 10.1038/s41598-023-35759-4. Sci Rep. 2023. PMID: 37253802 Free PMC article.
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
NLRP3 inflammasome in NMDA-induced retinal excitotoxicity.
Tsoka P, Barbisan PR, Kataoka K, Chen XN, Tian B, Bouzika P, Miller JW, Paschalis EI, Vavvas DG. Tsoka P, et al. Among authors: kataoka k. Exp Eye Res. 2019 Apr;181:136-144. doi: 10.1016/j.exer.2019.01.018. Epub 2019 Jan 29. Exp Eye Res. 2019. PMID: 30707890 Free PMC article.
Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study.
Tanaka K, Koizumi H, Tamashiro T, Itagaki K, Nakayama M, Maruko I, Wakugawa S, Terao N, Onoe H, Wakatsuki Y, Kasai A, Ogasawara M, Shintake H, Sugano Y, Yamamoto A, Kataoka K, Hasegawa T, Izumi T, Kawai M, Maruko R, Sekiryu T, Okada AA, Iida T, Mori R. Tanaka K, et al. Among authors: kataoka k. Jpn J Ophthalmol. 2022 Jul;66(4):379-385. doi: 10.1007/s10384-022-00922-3. Epub 2022 May 21. Jpn J Ophthalmol. 2022. PMID: 35595951
95 results